Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model

Published:2009-02 Issue: Volume:1254 Page:99-108
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Maeda Masashi,Furuichi Yasuhisa,Noto Takahisa,Matsuoka Nobuya,Mutoh Seitaro,Yoneda Yukio

Publisher

Elsevier BV

Subject

Developmental Biology,Neurology (clinical),Molecular Biology,General Neuroscience

Reference30 articles.

1. Ethanol plus caffeine (caffeinol) for treatment of ischemic stroke: preclinical experience;Aronowski;Stroke,2003

2. Endothelial-leukocyte adhesion molecules;Bevilacqua;Annu. Rev. Immunol.,1993

3. Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release;Cuadrado;J. Leukoc. Biol.,2008

4. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke;del Zoppo;Ann. Neurol.,1992

5. Neuroprotective action of tacrolimus (FK506) in focal and global cerebral ischemia in rodents: dose dependency, therapeutic time window and long-term efficacy;Furuichi;Brain Res.,2003

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging diagnostic markers and therapeutic targets in post-stroke hemorrhagic transformation and brain edema;Frontiers in Molecular Neuroscience;2023-12-21

2. Neuroprotective Action of Tacrolimus before and after Onset of Neonatal Hypoxic–Ischaemic Brain Injury in Rats;Cells;2023-11-20

3. Hemorrhagic Transformation of Ischemic Strokes;International Journal of Molecular Sciences;2023-09-14

4. Risk Factors, Pathophysiologic Mechanisms, and Potential Treatment Strategies of Futile Recanalization after Endovascular Therapy in Acute Ischemic Stroke;Aging and disease;2023

5. Neuroinflammation in hemorrhagic transformation after tissue plasminogen activator thrombolysis: Potential mechanisms, targets, therapeutic drugs and biomarkers;International Immunopharmacology;2021-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3